Newark Beth Israel Medical Center INC

Newark Beth Israel Medical Center INC was paid $380.16M by Medicaid between Jan 2018 and Dec 2024, across 673 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoNEWARK BETH ISRAEL MEDICAL CENTER INC
NEWARK, NJ 07112

33aNPI1215027966assigned 10/13/2006

33bProvider typeAdult Day Care Clinic/Center

28Total paid$380.16M

24GClaims3,336,430

24DCodes billed673

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Adult Day Care Clinic/Center providers in New Jersey

Rank by total paid#1 of 169

Median peer was paid$8.95M

This provider vs. median42×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	415,717	$56.58M
2019	420,343	$56.30M
2020	341,885	$40.75M
2021	427,402	$50.58M
2022	591,851	$57.47M
2023	604,358	$63.12M
2024incomplete	534,874	$55.37M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	15%	135,848	125,854	$56.30M
G0378	Hospital observation service, per hour	12%	40,602	34,490	$45.01M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	10%	78,442	71,407	$38.48M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	6.6%	54,077	46,582	$24.95M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	5.0%	15,029	14,409	$18.85M
OP250		2.6%	221,978	161,937	$9.96M
99282	Emergency department visit for the evaluation and management, low to moderate severity	2.5%	35,279	33,659	$9.69M
93303	Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study	2.5%	8,399	8,181	$9.54M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.8%	3,723	3,519	$6.87M
93320		1.8%	9,715	9,410	$6.67M
93325		1.7%	12,533	12,052	$6.28M
S9480	Intensive outpatient psychiatric services, per diem	1.6%	8,231	7,002	$5.97M

661 more codes

95810	Polysomnography; sleep staging with 4 or more additional parameters	1.4%	1,859	$5.36M
H0035	Mental health partial hospitalization, treatment, less than 24 hours	1.1%	18,246	$4.01M
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	54,743	$3.35M
OP370		<1%	27,651	$3.13M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	6,976	$3.12M
76818		<1%	12,262	$3.04M
76819	Fetal biophysical profile; without non-stress testing	<1%	13,750	$2.95M
11043		<1%	3,586	$2.91M
80053	Comprehensive metabolic panel	<1%	116,532	$2.63M
41899	Unlisted procedure, dentoalveolar structures	<1%	1,109	$2.44M
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	1,201	$1.94M
96375	Therapeutic injection; each additional sequential IV push	<1%	29,823	$1.93M
95813		<1%	2,950	$1.86M
36430		<1%	3,234	$1.84M
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	42,738	$1.83M
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	16,887	$1.74M
71046	Radiologic examination, chest; 2 views	<1%	27,110	$1.74M
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	10,275	$1.69M
74177	Computed tomography, abdomen and pelvis; with contrast material	<1%	9,213	$1.62M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	69,180	$1.61M
OP710		<1%	18,915	$1.57M
94760		<1%	15,898	$1.55M
54161		<1%	637	$1.51M
93458		<1%	1,136	$1.47M
95811		<1%	518	$1.44M
96361	Intravenous infusion, hydration; each additional hour	<1%	26,244	$1.42M
87902		<1%	11,648	$1.39M
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	4,620	$1.38M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	29,898	$1.36M
99213	Doctor's office visit, returning patient (routine)	<1%	18,432	$1.36M
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	843	$1.35M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	922	$1.33M
71045	Radiologic examination, chest; single view	<1%	22,691	$1.30M
OP272		<1%	27,925	$1.20M
36415	Collection of venous blood by venipuncture	<1%	164,438	$1.12M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	4,067	$1.10M
99214	Doctor's office visit, returning patient (more involved)	<1%	11,177	$1.07M
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	936	$1.04M
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	115,560	$1.04M
93017		<1%	2,185	$984K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	1,956	$983K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	4,878	$976K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	10,946	$975K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	9,116	$966K
J9271	Injection, pembrolizumab, 1 mg	<1%	218	$966K
69436	Tympanostomy (requiring insertion of ventilating tube), general anesthesia	<1%	634	$931K
11046		<1%	1,373	$923K
93970		<1%	2,750	$918K
92587		<1%	3,881	$896K
76820		<1%	5,911	$883K
11045		<1%	1,191	$862K
70450	Computed tomography, head or brain; without contrast material	<1%	9,729	$839K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	9,218	$814K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	35,408	$808K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	38,394	$796K
96409		<1%	1,807	$779K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,795	$749K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	5,754	$737K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	19,853	$736K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,530	$721K
94729		<1%	3,307	$695K
94060		<1%	2,157	$694K
94010		<1%	3,137	$671K
OP258		<1%	71,723	$669K
90791	Psychiatric diagnostic evaluation	<1%	7,284	$663K
95782		<1%	231	$656K
92579		<1%	2,579	$628K
76801		<1%	6,602	$617K
90837	Psychotherapy session, about an hour	<1%	8,447	$612K
82962		<1%	48,625	$607K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,650	$586K
90834	Psychotherapy session, about 45 minutes	<1%	10,793	$582K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	683	$578K
96415		<1%	1,986	$570K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	1,620	$566K
78815	Positron emission tomography (PET) for limited area imaging	<1%	376	$565K
J2426	Injection, paliperidone palmitate extended release (invega sustenna), 1 mg	<1%	700	$545K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	10,322	$541K
75574		<1%	1,898	$534K
92567		<1%	4,913	$524K
96367		<1%	3,119	$493K
71275	Computed tomographic angiography, chest, with contrast material	<1%	3,726	$485K
94618		<1%	2,206	$484K
76825		<1%	1,603	$483K
76830	Ultrasound, transvaginal	<1%	3,600	$477K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	9,790	$476K
76770		<1%	3,325	$468K
71250		<1%	2,251	$465K
58558		<1%	208	$456K
86850		<1%	23,099	$456K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	9,964	$454K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	18,838	$434K
OP278		<1%	1,705	$433K
76827		<1%	1,641	$422K
90832	Psychotherapy session, about 30 minutes	<1%	7,804	$418K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	4,642	$417K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	9,213	$407K
96417		<1%	1,674	$402K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	1,401	$391K
76642		<1%	3,040	$386K
92557		<1%	1,273	$384K
93976		<1%	5,167	$383K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	1,713	$377K
G0379	Direct admission of patient for hospital observation care	<1%	6,194	$375K
93971		<1%	1,179	$370K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	2,278	$361K
93975		<1%	1,446	$351K
72125	Computed tomography, cervical spine; without contrast material	<1%	3,065	$349K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	3,056	$336K
94727		<1%	2,388	$312K
76813		<1%	2,135	$305K
93242		<1%	759	$302K
J0585	Injection, onabotulinumtoxina, 1 unit	<1%	433	$289K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	4,794	$285K
77412		<1%	1,069	$282K
80061	Lipid panel	<1%	12,167	$282K
99204	Doctor's office visit, new patient (more involved)	<1%	3,447	$281K
77066	Tomosynthesis, mammo	<1%	1,879	$275K
90792	Psychiatric diagnostic evaluation with medical services	<1%	3,759	$275K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	2,017	$275K
99215	Doctor's office visit, returning patient (complex)	<1%	2,567	$270K
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	1,974	$269K
87536		<1%	2,792	$267K
73630		<1%	5,230	$265K
73562		<1%	4,401	$265K
96411		<1%	594	$258K
77065	Tomosynthesis, mammo	<1%	2,711	$255K
73030		<1%	3,901	$255K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	19,860	$248K
80048	Basic metabolic panel (calcium, ionized)	<1%	12,003	$246K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	5,769	$242K
77080		<1%	2,251	$237K
97010		<1%	11,946	$232K
83655		<1%	4,522	$232K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	5,042	$218K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	8,704	$209K
84443	Thyroid stimulating hormone (TSH)	<1%	16,006	$209K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	4,552	$194K
97803		<1%	2,261	$184K
99203	Doctor's office visit, new patient (routine)	<1%	3,533	$183K
93312		<1%	235	$181K
93350		<1%	508	$181K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	3,611	$177K
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	<1%	1,030	$174K
73130		<1%	3,761	$172K
86900		<1%	23,743	$171K
J0897	Injection, denosumab, 1 mg	<1%	109	$170K
87086	Culture, bacterial; quantitative colony count, urine	<1%	15,112	$166K
88307		<1%	1,611	$165K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,434	$163K
73610		<1%	4,255	$160K
76536		<1%	1,255	$158K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	7,104	$153K
99205	Prolong outpt/office vis	<1%	1,397	$153K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	168	$149K
73590		<1%	3,088	$147K
85027		<1%	26,855	$144K
80197		<1%	5,224	$140K
83036	Hemoglobin; glycosylated (A1C)	<1%	10,925	$140K
93225		<1%	212	$140K
S9484	Crisis intervention mental health services, per hour	<1%	390	$139K
69210		<1%	408	$138K
59025	Fetal non-stress test	<1%	892	$137K
72110		<1%	1,652	$135K
83880		<1%	16,947	$135K
83021		<1%	4,699	$129K
96376		<1%	8,341	$128K
76870		<1%	1,138	$126K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	2,730	$126K
64642		<1%	55	$124K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	3,351	$123K
73110		<1%	2,241	$121K
C9290	Injection, bupivacaine liposome, 1 mg	<1%	1,202	$119K
76821		<1%	654	$119K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	8,153	$118K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	2,751	$118K
93923		<1%	349	$116K
88342		<1%	5,650	$115K
85610		<1%	36,477	$115K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	913	$114K
83735		<1%	35,822	$113K
86360		<1%	2,695	$112K
93886		<1%	154	$112K
88142		<1%	2,761	$111K
97162		<1%	2,813	$110K
97802		<1%	920	$109K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	1,952	$106K
74018		<1%	2,336	$103K
93798		<1%	1,179	$102K
82728		<1%	6,616	$102K
81001		<1%	25,926	$101K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	322	$100K
77336		<1%	705	$100K
96401		<1%	710	$100K
71271		<1%	525	$97K
85007		<1%	16,860	$97K
90677		<1%	2,793	$97K
70486		<1%	999	$96K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	264	$95K
86359		<1%	2,695	$95K
97161		<1%	2,436	$93K
87081		<1%	3,064	$92K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	1,087	$92K
81003		<1%	16,411	$92K
86901		<1%	23,818	$90K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	140	$89K
84484		<1%	26,465	$88K
74022		<1%	1,216	$87K
81025		<1%	12,206	$86K
87070		<1%	3,889	$86K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	5,439	$86K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	1,797	$86K
86592		<1%	7,423	$83K
87340		<1%	22,616	$83K
93304		<1%	181	$83K
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	1,264	$81K
19083		<1%	55	$81K
86922		<1%	1,499	$80K
84439		<1%	8,488	$80K
86336		<1%	999	$79K
82247		<1%	4,015	$77K
93321		<1%	229	$76K
73090		<1%	2,135	$75K
86480		<1%	1,559	$74K
86355		<1%	2,695	$73K
54150		<1%	26	$72K
84702		<1%	9,168	$72K
87040		<1%	5,236	$71K
86902		<1%	1,575	$71K
94726		<1%	495	$70K
72100		<1%	1,224	$69K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	403	$69K
85730		<1%	30,587	$68K
86357		<1%	2,694	$67K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	1,788	$67K
95806		<1%	193	$63K
73560		<1%	1,493	$61K
J2785	Injection, regadenoson, 0.1 mg	<1%	1,053	$59K
D7140	Extraction, erupted tooth or exposed root	<1%	1,816	$55K
10060		<1%	830	$55K
84100		<1%	18,554	$54K
73502		<1%	1,580	$54K
85347		<1%	1,466	$54K
G0008	Administration of influenza virus vaccine	<1%	4,684	$53K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	5,950	$52K
36600		<1%	877	$51K
73521		<1%	1,027	$51K
87799		<1%	1,116	$50K
36591		<1%	1,694	$50K
86923		<1%	1,361	$50K
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	24,220	$49K
82542		<1%	2,147	$48K
73060		<1%	1,024	$48K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	873	$47K
73564		<1%	694	$47K
88341		<1%	1,724	$47K
0296T		<1%	217	$45K
93243		<1%	209	$45K
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	<1%	621	$45K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,238	$45K
82248		<1%	5,960	$45K
82803		<1%	2,514	$44K
76937		<1%	418	$43K
A9270	Non-covered item or service	<1%	25,286	$42K
D0140	Limited oral evaluation - problem focused	<1%	2,757	$42K
93880		<1%	101	$41K
83615		<1%	8,343	$41K
87497		<1%	598	$40K
C1769	Guide wire	<1%	3,367	$40K
86300		<1%	1,560	$38K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	54	$37K
36416		<1%	1,871	$37K
87186		<1%	2,640	$37K
P9040	Red blood cells, leukocytes reduced, irradiated, each unit	<1%	164	$36K
82805		<1%	1,108	$36K
S2900	Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure)	<1%	71	$35K
J2704	Injection, propofol, 10 mg	<1%	19,572	$34K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	10,079	$34K
73140		<1%	556	$33K
73552		<1%	1,265	$33K
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	3,060	$33K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	8,980	$33K
82607		<1%	2,989	$33K
12001		<1%	636	$33K
12011		<1%	628	$33K
83550		<1%	4,149	$33K
81401		<1%	826	$32K
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	21,866	$32K
85045		<1%	10,686	$32K
82950		<1%	1,352	$31K
83690		<1%	19,453	$31K
Q3014	Telehealth originating site facility fee	<1%	5,904	$31K
86828		<1%	704	$31K
86803		<1%	4,174	$31K
64640		<1%	13	$30K
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	4,819	$30K
86704		<1%	1,831	$30K
73080		<1%	843	$29K
87210		<1%	5,066	$29K
C1760	Closure device, vascular (implantable/insertable)	<1%	1,173	$29K
70491		<1%	221	$29K
88304		<1%	2,723	$28K
83540		<1%	4,387	$28K
85055		<1%	1,324	$28K
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	<1%	835	$28K
D0150	Comprehensive oral evaluation - new or established patient	<1%	1,235	$28K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	907	$27K
76641		<1%	84	$27K
82043		<1%	2,283	$26K
C1889	Implantable/insertable device, not otherwise classified	<1%	204	$26K
85384		<1%	2,503	$26K
73120		<1%	555	$25K
75561		<1%	43	$25K
86920		<1%	500	$25K
90472	Immunization administration, each additional vaccine (list separately)	<1%	4,479	$25K
81243		<1%	706	$25K
93505		<1%	18	$25K
90715		<1%	3,972	$24K
74174		<1%	138	$24K
95700		<1%	404	$23K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	724	$23K
96402		<1%	210	$22K
82746		<1%	2,244	$22K
97116		<1%	1,378	$22K
96450		<1%	32	$20K
97164		<1%	678	$20K
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	17,548	$20K
D1206	Topical application of fluoride varnish	<1%	1,354	$20K
73620		<1%	450	$20K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	32,617	$20K
73600		<1%	777	$20K
77334		<1%	34	$19K
92582		<1%	67	$19K
93308		<1%	155	$19K
29581		<1%	144	$19K
87400		<1%	1,578	$19K
J1453	Injection, fosaprepitant, 1 mg	<1%	397	$19K
73070		<1%	633	$18K
87147		<1%	1,367	$18K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	6,801	$18K
87077		<1%	2,384	$18K
73100		<1%	604	$18K
87428		<1%	498	$18K
D1120	Dental cleaning, child	<1%	1,306	$18K
76942		<1%	642	$18K
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	10,107	$18K
90853	Group psychotherapy (other than of a multiple-family group)	<1%	481	$17K
G0009	Administration of pneumococcal vaccine	<1%	2,853	$17K
42830		<1%	13	$16K
77290		<1%	49	$16K
D0210	Intraoral - complete series of radiographic images	<1%	647	$16K
81002		<1%	3,925	$16K
90674		<1%	2,696	$16K
82570		<1%	2,842	$16K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	542	$15K
84156		<1%	2,905	$15K
86708		<1%	1,054	$15K
93925		<1%	32	$14K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	296	$14K
76885		<1%	85	$13K
84550		<1%	3,425	$13K
77417		<1%	106	$13K
86762		<1%	1,735	$13K
76775		<1%	101	$12K
87522	Neg quan hep c or qual rna	<1%	373	$12K
85651		<1%	4,647	$12K
C1874	Stent, coated/covered, with delivery system	<1%	44	$12K
J1631	Injection, haloperidol decanoate, per 50 mg	<1%	648	$12K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	8,965	$12K
17250		<1%	53	$11K
83605		<1%	3,743	$11K
86140		<1%	4,655	$11K
D1110	Prophylaxis - adult	<1%	722	$11K
0001A		<1%	334	$11K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	1,162	$11K
95711		<1%	59	$11K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	577	$11K
92611		<1%	29	$11K
J0690	Injection, cefazolin sodium, 500 mg	<1%	5,117	$11K
82378		<1%	846	$11K
J1644	Injection, heparin sodium, per 1000 units	<1%	2,517	$10K
87205		<1%	2,832	$10K
87999		<1%	461	$10K
87496		<1%	193	$10K
84153		<1%	519	$10K
76882		<1%	88	$10K
85378		<1%	5,373	$10K
92652		<1%	28	$10K
88313		<1%	552	$10K
D0330	Panoramic radiographic image	<1%	923	$9K
J1756	Injection, iron sucrose, 1 mg	<1%	351	$9K
86870		<1%	152	$9K
Q9957	Injection, perflutren lipid microspheres, per ml	<1%	933	$9K
0002A		<1%	272	$9K
87808		<1%	2,928	$9K
86664		<1%	271	$9K
87486		<1%	764	$9K
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	2,133	$9K
96368		<1%	452	$9K
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	7,127	$9K
87088		<1%	4,012	$8K
J9370	Vincristine sulfate, 1 mg	<1%	733	$8K
77072		<1%	116	$8K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,044	$8K
84480		<1%	659	$8K
86039		<1%	421	$8K
A9577	Injection, gadobenate dimeglumine (multihance), per ml	<1%	749	$8K
85660		<1%	1,651	$7K
72197		<1%	15	$7K
86665		<1%	392	$7K
84132		<1%	3,577	$7K
86787		<1%	339	$7K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	6,451	$7K
90785		<1%	132	$7K
77086		<1%	164	$7K
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	<1%	399	$7K
85240		<1%	252	$7K
D0120	Dental checkup, returning patient	<1%	461	$7K
D0220	Intraoral - periapical first radiographic image	<1%	1,926	$7K
93041		<1%	116	$6K
98968		<1%	833	$6K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	13	$6K
83020		<1%	844	$6K
82270		<1%	1,260	$6K
80076		<1%	509	$6K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	12	$6K
90710		<1%	368	$6K
87581		<1%	764	$6K
83883		<1%	525	$6K
89051		<1%	644	$6K
D2392	Resin-based composite - two surfaces, posterior, primary or permanent	<1%	157	$6K
J2060	Injection, lorazepam, 2 mg	<1%	1,462	$6K
15853		<1%	193	$6K
A9579	Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml	<1%	608	$6K
J1815	Injection, insulin, per 5 units	<1%	1,740	$6K
29125		<1%	191	$6K
72081		<1%	52	$5K
72050		<1%	110	$5K
J1630	Injection, haloperidol, up to 5 mg	<1%	1,734	$5K
87075		<1%	408	$5K
74240		<1%	38	$5K
A9502	Technetium tc-99m tetrofosmin, diagnostic, per study dose	<1%	327	$5K
90651		<1%	509	$5K
D0145	Oral evaluation for a patient under three years of age	<1%	353	$5K
G0010	Administration of hepatitis b vaccine	<1%	256	$5K
78306		<1%	33	$5K
85380		<1%	720	$5K
C8930	Transthoracic echocardiography, with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with physician supervision	<1%	12	$5K
93922		<1%	39	$5K
72040		<1%	65	$5K
70498		<1%	27	$5K
87150		<1%	280	$5K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	507	$5K
84165		<1%	810	$5K
90686		<1%	778	$5K
84703		<1%	2,112	$5K
82550		<1%	2,409	$4K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	2,697	$4K
82375		<1%	683	$4K
83010		<1%	602	$4K
86317		<1%	911	$4K
88312		<1%	120	$4K
74160		<1%	14	$4K
J3535	Drug administered through a metered dose inhaler	<1%	1,690	$4K
82784		<1%	277	$4K
85018		<1%	3,338	$4K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	218	$4K
72131		<1%	37	$4K
80179		<1%	1,348	$4K
84030		<1%	109	$4K
98967		<1%	771	$4K
72141		<1%	14	$4K
72070		<1%	55	$4K
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	1,816	$4K
84481		<1%	355	$3K
77280		<1%	13	$3K
86880		<1%	339	$3K
20610		<1%	15	$3K
93247		<1%	13	$3K
D0190		<1%	652	$3K
82010		<1%	1,629	$3K
86706		<1%	299	$3K
12002		<1%	100	$3K
87631		<1%	139	$3K
J3475	Injection, magnesium sulfate, per 500 mg	<1%	2,048	$3K
86304		<1%	206	$3K
80177		<1%	671	$2K
87807		<1%	335	$2K
D7210	Extraction, erupted tooth requiring removal of bone and/or sectioning of tooth	<1%	73	$2K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	2,360	$2K
82397		<1%	259	$2K
80164		<1%	267	$2K
84145		<1%	408	$2K
86003		<1%	14	$2K
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	469	$2K
83001		<1%	59	$2K
90739		<1%	40	$2K
OP637		<1%	3,687	$2K
99201		<1%	27	$2K
84146		<1%	46	$2K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	46	$2K
74230		<1%	30	$2K
D0274	Bitewings - four radiographic images	<1%	249	$2K
90381		<1%	14	$2K
83050		<1%	652	$2K
82533		<1%	139	$2K
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	<1%	85	$2K
A4648	Tissue marker, implantable, any type, each	<1%	61	$2K
87517		<1%	39	$2K
64488		<1%	31	$2K
J9267	Injection, paclitaxel, 1 mg	<1%	110	$2K
85041		<1%	2,035	$2K
85245		<1%	39	$2K
86790		<1%	41	$2K
82024		<1%	58	$2K
86334		<1%	241	$2K
86705		<1%	179	$2K
85014		<1%	2,072	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	42	$1K
97165		<1%	24	$1K
90656		<1%	734	$1K
87430		<1%	120	$1K
92523		<1%	12	$1K
J1953	Injection, levetiracetam, 10 mg	<1%	563	$1K
J0280	Injection, aminophyllin, up to 250 mg	<1%	475	$1K
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	935	$1K
73522		<1%	15	$1K
J3480	Injection, potassium chloride, per 2 meq	<1%	1,221	$1K
86780		<1%	267	$1K
80143		<1%	289	$1K
83520		<1%	41	$1K
99381		<1%	12	$1K
90716		<1%	710	$1K
97014		<1%	73	$1K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	17	$1K
L1830	Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf	<1%	58	$1K
86431		<1%	118	$1K
82985		<1%	82	$999.62
85652		<1%	680	$974.81
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	603	$973.74
90673		<1%	149	$925.03
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	<1%	491	$883.82
83521		<1%	87	$860.03
82977		<1%	69	$850.28
90620		<1%	109	$813.66
84436		<1%	275	$786.51
90380		<1%	12	$785.29
84466		<1%	99	$780.21
82330		<1%	152	$772.89
96377		<1%	22	$752.57
J0134	Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg	<1%	672	$747.94
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	262	$747.04
90682		<1%	71	$739.87
82140		<1%	375	$692.01
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	210	$656.11
90734		<1%	425	$636.36
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	158	$634.76
D0270		<1%	209	$609.00
D2391	Resin-based composite - one surface, posterior, primary or permanent	<1%	20	$608.00
84134		<1%	54	$599.71
J1940	Injection, furosemide, up to 20 mg	<1%	958	$592.17
86160		<1%	39	$575.26
85246		<1%	28	$563.16
J3370	Injection, vancomycin hcl, 500 mg	<1%	515	$562.67
96523		<1%	18	$560.45
90746		<1%	45	$540.67
36592		<1%	26	$539.76
0031A		<1%	30	$526.30
D0603		<1%	156	$500.00
29130		<1%	14	$442.12
88108		<1%	15	$437.62
77001		<1%	20	$431.82
85008		<1%	373	$431.54
86735		<1%	12	$419.13
84157		<1%	28	$406.22
88112		<1%	100	$371.51
82565		<1%	12	$347.00
98966		<1%	162	$344.61
D0230	Intraoral - periapical each additional radiographic image	<1%	179	$338.25
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	476	$335.91
90697		<1%	1,648	$322.53
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	461	$317.38
83930		<1%	146	$311.62
86038		<1%	19	$302.79
D0601		<1%	39	$300.00
82150		<1%	85	$293.61
D1208	Topical application of fluoride, excluding varnish	<1%	29	$290.00
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	901	$288.02
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	575	$287.31
90696		<1%	336	$286.01
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	130	$281.46
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	284	$272.91
90633		<1%	1,262	$248.99
86644		<1%	30	$247.84
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	598	$234.31
82274		<1%	87	$231.09
OP255		<1%	208	$230.09
90662		<1%	104	$222.42
90681		<1%	1,100	$222.04
A9561	Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries	<1%	35	$217.11
J0780	Injection, prochlorperazine, up to 10 mg	<1%	64	$216.06
90750		<1%	16	$215.62
90707		<1%	692	$210.87
80185		<1%	14	$203.85
80320		<1%	159	$203.55
90700		<1%	592	$189.84
82785		<1%	30	$169.44
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	2,129	$162.94
82945		<1%	15	$160.13
87101		<1%	36	$154.83
J1596	Injection, glycopyrrolate, 0.1 mg	<1%	455	$136.03
84154		<1%	16	$128.38
90744		<1%	16	$119.60
95873		<1%	12	$115.32
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	279	$103.12
82668		<1%	15	$102.73
J0461	Injection, atropine sulfate, 0.01 mg	<1%	15	$101.93
J1250	Injection, dobutamine hydrochloride, per 250 mg	<1%	12	$97.65
80329		<1%	82	$90.97
J1643	Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units	<1%	397	$87.23
J2003	Injection, lidocaine hydrochloride, 1 mg	<1%	358	$72.49
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	39	$71.59
J7510	Prednisolone oral, per 5 mg	<1%	68	$69.45
J1171	Injection, hydromorphone, 0.1 mg	<1%	176	$68.89
J8540	Dexamethasone, oral, 0.25 mg	<1%	162	$67.96
Q0144	Azithromycin dihydrate, oral, capsules/powder, 1 gram	<1%	230	$66.11
C1884	Embolization protective system	<1%	13	$64.46
D0602		<1%	17	$60.00
86141		<1%	30	$59.35
87102		<1%	82	$55.84
D0272	Bitewings - two radiographic images	<1%	12	$55.00
90648		<1%	507	$50.65
87493		<1%	14	$44.29
90698		<1%	195	$40.03
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	152	$35.93
J0692	Injection, cefepime hydrochloride, 500 mg	<1%	14	$29.74
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	38	$28.01
G8985	Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	25	$27.00
84520		<1%	47	$24.25
J1790	Injection, droperidol, up to 5 mg	<1%	30	$18.81
85460		<1%	13	$18.80
J0136	Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg	<1%	16	$18.00
J7121	5% dextrose in lactated ringers infusion, up to 1000 cc	<1%	15	$16.52
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	<1%	44	$15.51
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	<1%	16	$13.79
J2004	Injection, lidocaine hcl with epinephrine, 1 mg	<1%	24	$11.95
J0687	Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg	<1%	227	$11.03
J2470	Injection, pantoprazole sodium, 40 mg	<1%	37	$8.97
J0736	Injection, clindamycin phosphate, 300 mg	<1%	14	$7.06
Q0244	Injection, casirivimab and imdevimab, 1200 mg	<1%	27	$7.00
91303		<1%	17	$6.00
86225		<1%	13	$3.33
Q0245	Injection, bamlanivimab and etesevimab, 2100 mg	<1%	15	$3.00
Q0222	Injection, bebtelovimab, 175 mg	<1%	17	$2.00
J0401	Injection, aripiprazole (abilify maintena), 1 mg	<1%	13	$1.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	27	$0.00
D1330		0%	189	$0.00
C1753	Catheter, intravascular ultrasound	0%	12	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	38	$0.00
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	0%	19	$0.00
91300		0%	524	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTERRY, DARRELL (CEO)

Parent organizationRWJ BARNABAS HEALTH INC